BOD Motive?, page-2

First 2 Last

Share
Profile

Follow
rustys33

1,855 Posts.

533

13/04/22

07:20

Post #: 60819938
Share
Originally posted by LeMetier: ↑

At face value the BOD wants to sell Resapp @11.5c / share and in the process throw all the holders who bought in above that price, which is probably the majority, under the bus. And at the same time deny shareholders the growth in stock value that initially motivated their purchase.

But it could in fact be the case that the BOD after extensive consultation and lengthy consideration, unequivocally expect shareholders to vote NO!

If it is in fact the later then it is a low risk, potentially high reward strategy.

From which Resapp and its shareholders can expect:

research & development licence between Resapp and Pfizer
$3M cash
international recognition and validation for Resapp courtesy of Pfizer
an open door to FDA regulatory approval, amongst others
worldwide acceptance and usage of Resapp diagnostic tools not just for covid but also pneumonia, asthma, bronchiolitis and chronic obstructive pulmonary disease; as well as those still to be developed

The list goes on and on. And I expect enormous potential for my holdings to grow significantly over the coming years if Resapp builds a close relationship with Pfizer; or a company of similar standing.

From the outside we cannot know for sure if this is a clever strategic move by the BOD, but it very well may be. Plus it is a worthwhile thought experiment.

What is the BOD motive?

Expand

This is what I'm hoping. Part of the agreement may have been the endorsement of the scheme by the board. Perhaps there is also a fiduciary requirement to endorse based on current revenue and offer premium - I'm not sure how likely this is but it could be a factor.
RAP Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

JGH

Jade's strong gas exploration results another step towards Mongolian development

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

FHE

Frontier Energy achieves key milestone for Waroona energy project

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

From the Floor: Perth conference highlights